Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy

por Si, Yingnan, Xu, Yuanxin, Guan, JiaShiung, Chen, Kai, Kim, Seulhee, Yang, Eddy S., Zhou, Lufang, Liu, Xiaoguang Margaret
Publicado 2020

Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment

por Si, Yingnan, Guan, JiaShiung, Xu, Yuanxin, Chen, Kai, Kim, Seulhee, Zhou, Lufang, Jaskula-Sztul, Renata, Liu, X. Margaret
Publicado 2020

Antibody–Drug Conjugate to Treat Meningiomas

por Chen, Kai, Si, Yingnan, Ou, Jianfa, Guan, Jia-Shiung, Kim, Seulhee, Ernst, Patrick, Zhang, Ya, Zhou, Lufang, Han, Xiaosi, Liu, Xiaoguang (Margaret)
Publicado 2021

Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma

por Chen, Kai, Si, Yingnan, Guan, Jia-Shiung, Zhou, Zhuoxin, Kim, Seulhee, Kim, Taehyun, Shan, Liang, Willey, Christopher D., Zhou, Lufang, Liu, Xiaoguang
Publicado 2022

Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers

por Si, Yingnan, Chen, Kai, Ngo, Hanh Giai, Guan, Jia Shiung, Totoro, Angela, Zhou, Zhuoxin, Kim, Seulhee, Kim, Taehyun, Zhou, Lufang, Liu, Xiaoguang
Publicado 2022

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer

por Si, Yingnan, Zhang, Ya, Ngo, Hanh Giai, Guan, Jia-Shiung, Chen, Kai, Wang, Qing, Singh, Ajeet Pal, Xu, Yuanxin, Zhou, Lufang, Yang, Eddy S., Liu, Xiaoguang (Margaret)
Publicado 2021

Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers

por Si, Yingnan, Zhang, Ya, Guan, Jia-Shiung, Ngo, Hanh Giai, Totoro, Angela, Singh, Ajeet Pal, Chen, Kai, Xu, Yuanxin, Yang, Eddy S., Zhou, Lufang, Liu, Runhua, Liu, Xiaoguang (Margaret)
Publicado 2021